N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction

被引:6
|
作者
Ikeda, Nahoko [1 ]
Yasu, Takanori [1 ]
Nishikimi, Toshio [1 ]
Nakamura, Tomohiro [1 ]
Kubo, Norifumi [1 ]
Kawakami, Masanobu [1 ]
Momomura, Shin-ichi [1 ]
Saito, Muneyasu [1 ]
机构
[1] Dokkyo Univ, Sch Med, Dept Hypertens & Cardiorenal Med, Mibu, Tochigi 3210293, Japan
关键词
exercise; natriuretic peptide; myocardial infarction; cardiac rehabilitation;
D O I
10.1016/j.regpep.2006.12.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Left ventricular end-diastolic pressure (LVEDP) during exercise workload is an important parameter to guide an exercise prescription for patients with cardiovascular disease. Plasma levels of neuro-hormonal factors can be used as a reflection of real-time LVEDP, but its utility is limited by its short half-life. By contrast, the N-terminal fragment of pro-ANP (NT-ANP) has a longer half-life of 1 h. Objective: To determine whether plasma NT-ANP levels at 30 min after exercise can be used as a marker of LVEDP during peak exercise workload in patients with previous myocardial infarction. Patients: Twenty patients with a previous history of myocardial infarction. Interventions: Cardiopulmonary exercise test was performed to determine peak VO2 and anaerobic threshold. Plasma levels of ANP, BNP, NT-ANP, vasopressin and plasma catecholamine were measured at rest, maximum exercise, and 30 min after exercise (recovery). Results: With the exception of NT-ANP, the levels of each of neuro-hormonal factors peaked at maximum exercise and returned to baseline at recovery. By contrast, NT-ANP levels also increased at peak exercise but remained elevated at 30 min after exercise. Furthermore, NT-ANP levels at recovery correlated with ANP levels at maximum exercise (p < 0.01, R=0.75), left ventricular ejection fraction (p < 0.02, R=-0.54) and left ventricular systolic dimension (p < 0.015, R=0.50). Conclusion: Plasma NT-ANP levels at 30 min after exercise reflect ANP levels at maximum exercise and left ventricular overload during exercise. These data indicate that plasma NT-ANP after exercise may be a useful parameter to guide prescription of cardiac rehabilitation. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:154 / 158
页数:5
相关论文
共 50 条
  • [1] N-terminal pro-atrial natriuretic peptide response to acute exercise in depressed patients and healthy controls
    Krogh, Jesper
    Stroehle, Andreas
    Westrin, Asa
    Klausen, Tobias
    Jorgensen, Martin Balslev
    Nordentoft, Merete
    PSYCHONEUROENDOCRINOLOGY, 2011, 36 (05) : 656 - 663
  • [2] Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide
    Jarai, R
    Iordanova, N
    Jarai, R
    Raffetseder, A
    Woloszczuk, W
    Gyöngyösi, M
    Geyer, G
    Wojta, J
    Huber, K
    EUROPEAN HEART JOURNAL, 2005, 26 (03) : 250 - 256
  • [3] N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction
    Squire, IB
    O'Brien, RJ
    Demme, B
    Davies, JE
    Ng, LL
    CLINICAL SCIENCE, 2004, 107 (03) : 309 - 316
  • [4] N-Terminal Pro-Atrial Natriuretic Peptide Measurement in Plasma Suggests Covalent Modification
    Hunter, Ingrid
    Alehagen, Urban
    Dahlstrom, Ulf
    Rehfeld, Jens F.
    Crimmins, Dan L.
    Goetze, Jens P.
    CLINICAL CHEMISTRY, 2011, 57 (09) : 1327 - 1330
  • [5] Plasma levels of N-terminal peptide of pro-atrial natriuretic peptides in myoskeletal injuries
    Onuoha, GN
    Alpar, EK
    REGULATORY PEPTIDES, 2001, 99 (01) : 17 - 20
  • [6] Myocardial Infarction and N-Terminal Pro-Brain Natriuretic Peptide
    Arjamaa, Olli
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (09): : 1697 - 1697
  • [7] Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction
    Hammerer-Lercher, A
    Neubauer, E
    Müller, S
    Pachinger, O
    Puschendorf, B
    Mair, J
    CLINICA CHIMICA ACTA, 2001, 310 (02) : 193 - 197
  • [8] Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes
    Omland, T
    de Lemos, JA
    Morrow, DA
    Antman, EN
    Cannon, CP
    Hall, C
    Braunwald, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (04): : 463 - +
  • [9] Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure
    Potocki, M.
    Breidthardt, T.
    Reichlin, T.
    Hartwiger, S.
    Morgenthaler, N. G.
    Bergmann, A.
    Noveanu, M.
    Freidank, H.
    Taegtmeyer, A. B.
    Wetzel, K.
    Boldanova, T.
    Stelzig, C.
    Bingisser, R.
    Christ, M.
    Mueller, C.
    JOURNAL OF INTERNAL MEDICINE, 2010, 267 (01) : 119 - 129
  • [10] Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure
    Potocki, M.
    Breidthardt, T.
    Reichlin, T.
    Laule, K.
    Noveanu, M.
    Boldanova, T.
    Stelzig, C.
    Christ, M.
    Mueller, C.
    EUROPEAN HEART JOURNAL, 2008, 29 : 180 - 180